All Relations between Alzheimer Disease and insulin receptor

Reference Sentence Publish Date Extraction Date Species
Timothy M Hughes, Suzanne Craf. Cerebral insulin receptors: a nexus for vascular and metabolic contributions to Alzheimer's disease. Brain : a journal of neurology vol issue 2022 36402144 cerebral insulin receptors: a nexus for vascular and metabolic contributions to alzheimer's disease. 2022-11-19 2022-11-21 Not clear
Manon Leclerc, Philippe Bourassa, Cyntia Tremblay, Vicky Caron, Camille Sug\\xc3\\xa8re, Vincent Emond, David A Bennett, Fr\\xc3\\xa9d\\xc3\\xa9ric Calo. Cerebrovascular insulin receptors are defective in Alzheimer's disease. Brain : a journal of neurology vol issue 2022 36280236 cerebrovascular insulin receptors are defective in alzheimer's disease. 2022-10-24 2022-11-01 Not clear
Genaro G Ortiz, Miguel Huerta, H\\xc3\\xa9ctor A Gonz\\xc3\\xa1lez-Usigli, Erandis D Torres-S\\xc3\\xa1nchez, Daniela Lc Delgado-Lara, Ferm\\xc3\\xadn P Pacheco-Mois\\xc3\\xa9s, Mario A Mireles-Ram\\xc3\\xadrez, Blanca Mg Torres-Mendoza, Roxana I Moreno-Cih, Irma E Vel\\xc3\\xa1zquez-Brizuel. Cognitive disorder and dementia in type 2 diabetes mellitus. World journal of diabetes vol 13 issue 4 2022 35582669 at the receptor level, in aging and alzheimer's disease (ad) models, the amount of insulin receptors and their functions are decreased. 2022-05-18 2022-06-13 Not clear
Royal Patel, Karamjeet Kaur, Shamsher Sing. Protective effect of andrographolide against STZ induced Alzheimer's disease in experimental rats: possible neuromodulation and A\\xce\\xb2 Inflammopharmacology vol 29 issue 4 2021 34235591 protective effect of andrographolide against stz induced alzheimer's disease in experimental rats: possible neuromodulation and a\xce\xb2 stz is a glucosamine-nitrosourea compound, causes dysfunctioning of insulin receptors in the brain and disrupts glucose metabolism, produces cognitive decline and ad-like symptoms. 2021-07-23 2022-01-13 Not clear
Rajeev Taliyan, Sarathlal K Chandran, Violina Kakot. Therapeutic Approaches to Alzheimer's Type of Dementia: A Focus on FGF21 Mediated Neuroprotection. Current pharmaceutical design vol 25 issue 23 2020 31333086 with the identification of insulin and insulin receptors in some parts of the brain, it has become evident that certain metabolic conditions associated with insulin dysfunction like type 2 diabetes mellitus (t2dm), dyslipidemia, obesity etc., are also known to contribute to neurodegeneration mainly alzheimer's disease (ad). 2020-04-16 2022-01-13 Not clear
Jerzy Leszek, Elzbieta Trypka, Vadim V Tarasov, Ghulam Md Ashraf, Gjumrakch Alie. Type 3 Diabetes Mellitus: A Novel Implication of Alzheimers Disease. Current topics in medicinal chemistry vol 17 issue 12 2017 28049395 the brain of patients with alzheimer disease (ad) showed the evidence of reduced expression of insulin and neuronal insulin receptors, as compared with those of age-matched controls. 2017-07-05 2022-01-13 Not clear
Katrin Morgen, Lutz Fr\\xc3\\xb6lic. The metabolism hypothesis of Alzheimer's disease: from the concept of central insulin resistance and associated consequences to insulin therapy. Journal of neural transmission (Vienna, Austria : 1996) vol 122 issue 4 2015 25673434 insulin and insulin receptors are widely distributed in the brain and are impaired in the post-mortem alzheimer brain. 2015-12-16 2022-01-12 Not clear
Paola Castri, Luisa Iacovelli, Antonio De Blasi, Franco Giubilei, Arianna Moretti, Francesca Tari Capone, Ferdinando Nicoletti, Francesco Orz. Reduced insulin-induced phosphatidylinositol-3-kinase activation in peripheral blood mononuclear leucocytes from patients with Alzheimer's disease. The European journal of neuroscience vol 26 issue 9 2008 17986027 the epidemiological finding of an increased risk of dementia in patients with diabetes mellitus has raised the hypothesis that a dysfunction of the insulin receptors plays a role in the pathogenesis of alzheimer's disease (ad). 2008-03-14 2022-01-12 Not clear
N Henneberg, S Hoye. Desensitization of the neuronal insulin receptor: a new approach in the etiopathogenesis of late-onset sporadic dementia of the Alzheimer type (SDAT)? Archives of gerontology and geriatrics vol 21 issue 1 2005 15374226 this led us to hypothesize that the abnormal reduction in glucose utilization found in alzheimer brains is preceded by a desensitization of cerebral insulin receptors which might be due to enhanced levels of stress factors such as cortisol and catecholamines. 2005-03-14 2022-01-12 Not clear
L Fr\\xc3\\xb6lich, D Blum-Degen, H G Bernstein, S Engelsberger, J Humrich, S Laufer, D Muschner, A Thalheimer, A T\\xc3\\xbcrk, S Hoyer, R Z\\xc3\\xb6chling, K W Boissl, K Jellinger, P Riedere. Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. Journal of neural transmission (Vienna, Austria : 1996) vol 105 issue 4-5 1998 9720972 brain insulin and insulin receptors in aging and sporadic alzheimer's disease. 1998-10-30 2022-01-10 Not clear